TI Pharma

Scalable Life Sciences ondersteunde het Top Institute Pharma (TI Pharma) op het terrein van de public

Top Institute Pharma (TI Pharma) is a public-private partnership in which scientific and business
worlds work together on groundbreaking, multidisciplinary research aimed at improving the development of
socially valuable medicines. The research portfolio is based on the disease areas as specified in Priority
Medicines, a report by the World Health Organization (WHO). The knowledge gained in these projects provides
an important contribution to better, faster and less-expensive development of valuable new medicines.

Corporate Communications, Investor Relations and Public Affairs for Life Sciences